Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysis

Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysis - Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023201

Enrollment

Registered

2016-07-16

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endstage chronic kidney disease

Interventions

L-type Ca channel blocker amlodipine is administered for 4 weeks, and then it is changed to L/N-type Ca channel blocker cilnidipine.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable hemodialysis patients undergoing regular dialysis treatment for at least for 6 months

Exclusion criteria

Exclusion criteria: acute myocardial infarction or cerebrovascular disease occurring within a half year and atrial fibrillation

Design outcomes

Primary

Measure	Time frame
Changes in heart rate or QTc during one hemodialysis session after taking L/N Ca blocker for 4 weeks	—

Countries

Japan

Contacts

Public ContactTakeshi Iida

Moriguchi Keijinnkai Hospital Department of Nephrology and Dialysis

t.iida506@gmail.com06-6906-9000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026